Vidasym Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.48M

  • Investors
  • 4

Vidasym General Information

Description

Operator of a clinical-stage company intended to cure chronic kidney disease. The company is developing small molecule drugs primarily for renal disorders, providing patients to get relief from diseases.

Contact Information

Website
www.vidasym.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • 2201 West Campbell Park Drive
  • Suite 13
  • Chicago, IL 60612
  • United States
+1 (847)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 2201 West Campbell Park Drive
  • Suite 13
  • Chicago, IL 60612
  • United States
+1 (847)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vidasym Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Apr-2016 $1.48M Completed Clinical Trials - General
5. Grant 11-May-2015 Completed Clinical Trials - General
4. Grant 31-Aug-2014 Completed Clinical Trials - General
3. Grant 31-Aug-2013 Completed Startup
2. Angel (individual) $2.5M $2.5M Completed Startup
1. Angel (individual) Completed Startup
To view Vidasym’s complete valuation and funding history, request access »

Vidasym Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Arthritis and Musculoskeletal Diseases Other
U.S. Department of Health and Human Services Government
Alan Lau Angel (individual) Minority
National Institutes of Health Government
To view Vidasym’s complete investors history, request access »

Vidasym FAQs

  • When was Vidasym founded?

    Vidasym was founded in 2009.

  • Where is Vidasym headquartered?

    Vidasym is headquartered in Chicago, IL.

  • What industry is Vidasym in?

    Vidasym’s primary industry is Drug Discovery.

  • Is Vidasym a private or public company?

    Vidasym is a Private company.

  • What is Vidasym’s current revenue?

    The current revenue for Vidasym is .

  • How much funding has Vidasym raised over time?

    Vidasym has raised $2.5M.

  • Who are Vidasym’s investors?

    National Institutes of Arthritis and Musculoskeletal Diseases, U.S. Department of Health and Human Services, Alan Lau, and National Institutes of Health have invested in Vidasym.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »